5FO9 | Lipid Binding Protein | date | Nov 18, 2015 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Human Complement C3b In Complex With Cr 17) | ||||||||||||||
authors | F.Forneris, J.Wu, X.Xue, P.Gros | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Complement C3 Beta Chain Chain: A, D Fragment: Residues 23-667 Synonym: C3 And Pzp-Like Alpha-2-Macroglobulin Domain-Conta Protein 1; |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Other_details: Purified From Human Plasma | ||||||||||||||
Molecule: Complement C3b Alpha' Chain Chain: B, E Fragment: Ccp Domains, Residues 749-1663 |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Other_details: Purified From Human Plasma | ||||||||||||||
Molecule: Complement Receptor Type 1 Chain: C, F Fragment: Residues 942-1136 Synonym: C3bc4b Receptor, Complement Cr1, Cd35 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Komagataella Pastoris Expression_system_taxid: 4922 | ||||||||||||||
symmetry | Space Group: P 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 3.30 Å | ||||||||||||
ligand | NAG | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode., Forneris F, Wu J, Xue X, Ricklin D, Lin Z, Sfyroera G, Tzekou A, Volokhina E, Granneman JC, Hauhart R, Bertram P, Liszewski MK, Atkinson JP, Lambris JD, Gros P, EMBO J. 2016 Mar 24. pii: e201593673. PMID:27013439 |
Data retrieval |
View 5FO9 in 3D |
Visual 3D analysis of 5FO9 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5FO9 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |